Pharmacodynamics OHPH is a progestin, or a synthetic progestogen, and hence is an agonist of the progesterone receptor, the biological target of progestogens like progesterone. The progestogenic potency of OHPH in the uterus is equal to or greater than that of progesterone when administered by subcutaneous injection in animals. Its potency in animals likewise appears to be similar to that of<unk>  caproate. Pharmacokinetics OHPH shows a pronounced depot effect when administered by subcutaneous injection in animals, similarly to the closely related medication<unk>  caproate. The oral activity of OHPH in animals does not appear to have been assessed.
Hydroxyprogesterone heptanoate
Estradiol undecylate
Estradiol dienantate
Hydroxyprogesterone caproate
Estradiol enantate
Chloromethylandrostenediol
Androstenediol dipropionate
Lipoidal estradiol